121 related articles for article (PubMed ID: 12471806)
1. [Contrast media in ultrasonography: from synthesis to clinical use. The Sonovue example].
Schneider M
Ann Cardiol Angeiol (Paris); 2002 Sep; 51(4):218-20. PubMed ID: 12471806
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound imaging with SonoVue: low mechanical index real-time imaging.
Bauer A; Solbiati L; Weissman N
Acad Radiol; 2002 Aug; 9 Suppl 2():S282-4. PubMed ID: 12188249
[No Abstract] [Full Text] [Related]
3. Intracavitary applications of ultrasound contrast agents in hepatogastroenterology.
Sparchez Z; Radu P; Sparchez M; Vasile T; Anton O; Tantau M
J Gastrointestin Liver Dis; 2013 Sep; 22(3):349-53. PubMed ID: 24078996
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced ultrasound using bolus injections of contrast agent for assessment of postprandial microvascular blood volume in human skeletal muscle.
Mertz KH; Bülow J; Holm L
Clin Physiol Funct Imaging; 2018 Sep; 38(5):864-871. PubMed ID: 29282853
[TBL] [Abstract][Full Text] [Related]
5. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
[TBL] [Abstract][Full Text] [Related]
6. Enhancing effects of SonoVue, a microbubble sonographic contrast agent, on high-intensity focused ultrasound ablation in rabbit livers in vivo.
Luo W; Zhou X; Ren X; Zheng M; Zhang J; He G
J Ultrasound Med; 2007 Apr; 26(4):469-76. PubMed ID: 17384044
[TBL] [Abstract][Full Text] [Related]
7. High Frame-Rate Contrast Echocardiography: In-Human Demonstration.
Toulemonde MEG; Corbett R; Papadopoulou V; Chahal N; Li Y; Leow CH; Cosgrove DO; Eckersley RJ; Duncan N; Senior R; Tang MX
JACC Cardiovasc Imaging; 2018 Jun; 11(6):923-924. PubMed ID: 29248652
[No Abstract] [Full Text] [Related]
8. Enhanced left ventricular endocardial border delineation with an intravenous injection of SonoVue, a new echocardiographic contrast agent: A European multicenter study.
Senior R; Andersson O; Caidahl K; Carlens P; Herregods MC; Jenni R; Kenny A; Melcher A; Svedenhag J; Vanoverschelde JL; Wandt B; Widgren BR; Williams G; Guerret P; la Rosee K; Agati L; Bezante G
Echocardiography; 2000 Nov; 17(8):705-11. PubMed ID: 11153016
[TBL] [Abstract][Full Text] [Related]
9. Bolus versus continuous infusion of microbubble contrast agent for liver ultrasound by using an automatic power injector in humans: A pilot study.
Quaia E; Gennari AG; Angileri R; Cova MA
J Clin Ultrasound; 2016; 44(3):136-42. PubMed ID: 26302446
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic performance of SonoVue-enhanced color duplex sonography of vascular structures.
Spinazzi A; Llull JB
Acad Radiol; 2002 May; 9 Suppl 1():S246-50. PubMed ID: 12019881
[No Abstract] [Full Text] [Related]
11. Effects of a microbubble ultrasound contrast agent on high-intensity focused ultrasound for uterine fibroids: a randomised controlled trial.
Chen Y; Jiang J; Zeng Y; Tian X; Zhang M; Wu H; Zhou H
Int J Hyperthermia; 2018 Dec; 34(8):1311-1315. PubMed ID: 29301450
[TBL] [Abstract][Full Text] [Related]
12. In vitro acoustic characterisation of four intravenous ultrasonic contrast agents at 30 MHz.
Moran CM; Watson RJ; Fox KA; McDicken WN
Ultrasound Med Biol; 2002 Jun; 28(6):785-91. PubMed ID: 12113791
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound contrast agent delivered per os first diagnoses pharyngoesophageal tumour.
Antypa E; Cokkinos DD; Kalogeropoulos I; Tomais D; Piperopoulos PN
JBR-BTR; 2013; 96(2):69-71. PubMed ID: 23847823
[TBL] [Abstract][Full Text] [Related]
14. Measurement of pulmonary transit time in healthy cats by use of ultrasound contrast media "Sonovue®": feasibility, reproducibility, and values in 42 cats.
Streitberger A; Hocke V; Modler P
J Vet Cardiol; 2013 Sep; 15(3):181-7. PubMed ID: 23933477
[TBL] [Abstract][Full Text] [Related]
15. Off-Label Use of Ultrasound Contrast Agents for Intravenous Applications in Children: Analysis of the Existing Literature.
Rosado E; Riccabona M
J Ultrasound Med; 2016 Mar; 35(3):487-96. PubMed ID: 26839372
[TBL] [Abstract][Full Text] [Related]
16. Pseudo-left ventricle apical hypertrophy: bedside diagnosis with SonoVue contrast.
Comella A; Magnacca M
Echocardiography; 2004 Aug; 21(6):563-4. PubMed ID: 15298696
[No Abstract] [Full Text] [Related]
17. SonoVue, a new ultrasound contrast agent.
Schneider M
Eur Radiol; 1999; 9 Suppl 3():S347-8. PubMed ID: 10602926
[No Abstract] [Full Text] [Related]
18. Effect of SonoVue on the synovial membrane in rabbit knees.
Domenech E; Berná-Serna Jde D; Polo L; Reus M; Berná-Mestre Jde D; Canteras M
J Ultrasound Med; 2011 Sep; 30(9):1241-6. PubMed ID: 21876095
[TBL] [Abstract][Full Text] [Related]
19. Ovine model to evaluate ovarian vascularization by using contrast-enhanced sonography.
Marret H; Brewer M; Giraudeau B; Tranquart F; Voelker K; Satterfield W
Comp Med; 2005 Apr; 55(2):150-5. PubMed ID: 15884777
[TBL] [Abstract][Full Text] [Related]
20. Oral and I.V. contrast enhanced ultrasonography of the digestive tract--a useful completion of the B-mode examination: a literature review and an exhaustive illustration through images.
Neciu C; Badea R; Chiorean L; Badea AF; Opincariu I
Med Ultrason; 2015 Mar; 17(1):62-73. PubMed ID: 25745660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
